Xlife Sciences Ltd. header image

Xlife Sciences Ltd.

XLS

Equity

ISIN CH0461929603 / Valor 46192960

SIX Swiss Exchange (2026-07-24)
CHF 16.50-3.51%

Xlife Sciences Ltd.
UMushroom community rating:

star star star star star
3.50 2 votes No rating yet
NegativeNeutralPositive

About company

The provided company page did not include substantive text, so based on the company name and typical activity in the sector, Xlife Sciences Ltd. is a life‑sciences firm that develops and commercializes health‑related products and services; its business is likely centered on research and development, regulatory interactions and the manufacture or outsourcing of pharmaceuticals, diagnostics or nutraceuticals, with commercial efforts focused on licensing, partnerships and product sales to healthcare providers, distributors and consumers. As with similar small‑to‑mid‑sized life‑sciences companies, value depends on the progress of its development pipeline, regulatory approvals, strategic collaborations and its ability to secure funding and scale manufacturing and distribution.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-26.7%1Y
-59.3%3Y
-65.6%5Y

Performance

61.3%1Y
64.1%3Y
59.4%5Y

Volatility

Market cap

116 M

Market cap (USD)

Daily traded volume (Shares)

2,788

Daily traded volume (Shares)

1 day high/low

25.9 / 24.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.50

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Timo R
Switzerland, 16 Apr 2025
star star star star star
.
Raphael Raufer
Switzerland, 16 Apr 2025
star star star star star
Leider schlechte Performance im Moment

EQUITIES OF THE SAME SECTOR

Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 35.01
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.20%USD 16.05
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.22%USD 56.55
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.48%EUR 12.48
Sotera Health Company
Sotera Health Company Sotera Health Company Valor: 57897071
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%USD 17.35
Limes Schlosskliniken AG
Limes Schlosskliniken AG Limes Schlosskliniken AG Valor: 38625581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%EUR 560.00
Robertet SA
Robertet SA Robertet SA Valor: 510354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%EUR 772.00
Surgery Partners Inc
Surgery Partners Inc Surgery Partners Inc Valor: 29308003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.35%USD 15.73
Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.35%USD 23.38
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%EUR 24.50